Abstract
Several embodiments of the present disclosure relate to glycotargeting therapeutics that are useful in the treatment of transplant rejection, autoimmune disease, food allergy, and immune response against a therapeutic agent. In several embodiments, the compositions are configured to target the liver and deliver antigens to which tolerance is desired. Methods and uses of the compositions for induction of immune tolerance are also disclosed herein.
Details
Title
Glycotargeting therapeutics
Author(s)
Hubbell, Jeffrey A ; Wilson, David Scott
Date
2017
Keywords
Note
Alternative title(s) :
(de) Glyco-targetierende therapeutika
(fr) Agents thérapeutiques de glycociblage
Other identifier(s)
EPO Family ID: 57730362
EPO Family ID: 56692928
EPO Family ID: 53762221
EPO Family ID: 57121450
EPO Family ID: 56692928
EPO Family ID: 53762221
EPO Family ID: 57121450
Patent number(s)
EP4385520 (A2)
JP2024063005 (A)
CN108430497 (B)
JP2024037920 (A)
JP7434248 (B2)
IL257958 (B2)
IL306015 (A)
US11801305 (B2)
US11793882 (B2)
IL257958 (B1)
CA2946064 (C)
AU2023203475 (A1)
US11666638 (B2)
IL283100 (B2)
US11654188 (B2)
US2023119325 (A1)
US2023115331 (A1)
US2023108299 (A1)
US2023093483 (A1)
AU2016325073 (B2)
KR20230003288 (A)
JP7082045 (B2)
JP2022070910 (A)
JP2022028673 (A)
MX2021012636 (A)
EP3909603 (A1)
ES2874884 (T3)
LT3107563 (T)
IL283100 (A)
IL247283 (B)
DK3107563 (T3)
EP3107563 (B1)
AU2021201504 (A1)
US10953101 (B2)
US10946079 (B2)
US10940209 (B2)
SG10202010936R (A)
EA036102 (B9)
AU2015233084 (B2)
US10821157 (B2)
EA036102 (B1)
JP6744227 (B2)
JP2020121981 (A)
US2020129629 (A1)
US2020129601 (A1)
US2020129625 (A1)
US2020121762 (A1)
HK1257845 (A1)
JP2018532722 (A)
US2018303951 (A1)
BR112018005409 (A2)
US2018271986 (A1)
MX2018003411 (A)
EA201890778 (A1)
CN108430497 (A)
US10046056 (B2)
EP3349784 (A1)
KR20180080195 (A)
IL257958 (A)
AU2016325073 (A1)
NZ723879 (A)
HK1232151 (A1)
US2017296636 (A9)
BR112016019274 (A2)
MX2016010835 (A)
EA201691686 (A1)
CA2998066 (A1)
WO2017046652 (A1)
JP2017507180 (A)
CN106456743 (A)
US2017007708 (A1)
EP3107563 (A2)
KR20160135214 (A)
SG11201606761R (A)
AU2015233084 (A1)
US2016243248 (A1)
US2016015821 (A1)
WO2015140648 (A3)
CA2946064 (A1)
WO2015140648 (A2)
JP2024063005 (A)
CN108430497 (B)
JP2024037920 (A)
JP7434248 (B2)
IL257958 (B2)
IL306015 (A)
US11801305 (B2)
US11793882 (B2)
IL257958 (B1)
CA2946064 (C)
AU2023203475 (A1)
US11666638 (B2)
IL283100 (B2)
US11654188 (B2)
US2023119325 (A1)
US2023115331 (A1)
US2023108299 (A1)
US2023093483 (A1)
AU2016325073 (B2)
KR20230003288 (A)
JP7082045 (B2)
JP2022070910 (A)
JP2022028673 (A)
MX2021012636 (A)
EP3909603 (A1)
ES2874884 (T3)
LT3107563 (T)
IL283100 (A)
IL247283 (B)
DK3107563 (T3)
EP3107563 (B1)
AU2021201504 (A1)
US10953101 (B2)
US10946079 (B2)
US10940209 (B2)
SG10202010936R (A)
EA036102 (B9)
AU2015233084 (B2)
US10821157 (B2)
EA036102 (B1)
JP6744227 (B2)
JP2020121981 (A)
US2020129629 (A1)
US2020129601 (A1)
US2020129625 (A1)
US2020121762 (A1)
HK1257845 (A1)
JP2018532722 (A)
US2018303951 (A1)
BR112018005409 (A2)
US2018271986 (A1)
MX2018003411 (A)
EA201890778 (A1)
CN108430497 (A)
US10046056 (B2)
EP3349784 (A1)
KR20180080195 (A)
IL257958 (A)
AU2016325073 (A1)
NZ723879 (A)
HK1232151 (A1)
US2017296636 (A9)
BR112016019274 (A2)
MX2016010835 (A)
EA201691686 (A1)
CA2998066 (A1)
WO2017046652 (A1)
JP2017507180 (A)
CN106456743 (A)
US2017007708 (A1)
EP3107563 (A2)
KR20160135214 (A)
SG11201606761R (A)
AU2015233084 (A1)
US2016243248 (A1)
US2016015821 (A1)
WO2015140648 (A3)
CA2946064 (A1)
WO2015140648 (A2)
Record Appears in
Scientific production and competences > SB - School of Basic Sciences > SB Archives > LMRP - Regenerative Medicine and Pharmacobiology Laboratory
Scientific production and competences > SV - School of Life Sciences > SV Archives > LMRP - Regenerative Medicine and Pharmacobiology Laboratory
Scientific production and competences > Non-academic units > TTO - Technology Transfer Office
Work produced at EPFL
Patents
Scientific production and competences > SV - School of Life Sciences > SV Archives > LMRP - Regenerative Medicine and Pharmacobiology Laboratory
Scientific production and competences > Non-academic units > TTO - Technology Transfer Office
Work produced at EPFL
Patents
Record creation date
2017-05-02